Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD

https://ift.tt/PzQ59md

Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD



from Sanofi - Aventis Groupe https://ift.tt/XA53xIt
via IFTTT

Post a Comment

0 Comments